Epidemiology and Management of Acquired Angioedema Due to C1 Inhibitor Deficiency
Mohammed Olaythah Alraddadi, Yousef Hussain J. Alharthi, Rayyan Fahad H. Altemani, Wejdan Mohammed S. Alshehri, Amal Nafea J. Alharbi, Raghad Saud A. Albalawi, Khawla Abdulrahman S. Alzahrani, Shuruq Mousa D. Albalawi, Sultan Suliman Q. Al-Ruwaili, Sultan Faraj Alruwaili, Mousa Amer M. Alshehri, Asma Saleh S. Alruwaili, Sarah Mohammad M. Ali, Ahmad Arafat A. Abualaz & Marah Saud Alenezi · Journal of Pharmaceutical Research International · 2021
AAE-C1-INH (acquired angioedema owing to C1-inhibitor (C1-INH) deficiency) is a dangerous illness that can lead to asphyxiation due to laryngeal edoema. Only around 1% to 2% of angioedema cases are classified as HAE or AAE, with HAE being 10 times more prevalent than AAE. The sol...